Sight Diagnostics completes US$28.7 million Series C funding

Consumer digital health fund Longliv Ventures has led the $27.8 million  Series C funding for Sight Diagnostics, a Tel Aviv-based company that provides patients with lab-grade complete blood count test results by finger prick in minutes. Other participants in the round include Jack Nicklaus II, a healthcare philanthropist and board member of the Nicklaus Children’s Health…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »